| DNA vaccine protection against SARS-CoV-2 in rhesus macaques J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ... Science 369 (6505), 806-811, 2020 | 1121 | 2020 |
| Correlates of protection against SARS-CoV-2 in rhesus macaques K McMahan, J Yu, NB Mercado, C Loos, LH Tostanoski, A Chandrashekar, ... Nature 590 (7847), 630-634, 2021 | 1073 | 2021 |
| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1054 | 2020 |
| Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 962 | 2020 |
| SARS-CoV-2 infection protects against rechallenge in rhesus macaques A Chandrashekar, J Liu, AJ Martinot, K McMahan, NB Mercado, L Peter, ... Science 369 (6505), 812-817, 2020 | 930 | 2020 |
| Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys P Abbink, RA Larocca, RA De La Barrera, CA Bricault, ET Moseley, ... Science 353 (6304), 1129-1132, 2016 | 553 | 2016 |
| Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women YC Ai-ris, K McMahan, J Yu, LH Tostanoski, R Aguayo, J Ansel, ... Jama 325 (23), 2370-2380, 2021 | 430 | 2021 |
| Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron J Liu, A Chandrashekar, D Sellers, J Barrett, C Jacob-Dolan, M Lifton, ... Nature 603 (7901), 493-496, 2022 | 352 | 2022 |
| Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) DH Barouch, FL Tomaka, F Wegmann, DJ Stieh, G Alter, ML Robb, ... The Lancet 392 (10143), 232-243, 2018 | 321 | 2018 |
| Neutralization of the SARS-CoV-2 Omicron BA. 1 and BA. 2 variants J Yu, AY Collier, M Rowe, F Mardas, JD Ventura, H Wan, J Miller, ... New England Journal of Medicine 386 (16), 1579-1580, 2022 | 315 | 2022 |
| Immunogenicity of Ad26. COV2. S vaccine against SARS-CoV-2 variants in humans G Alter, J Yu, J Liu, A Chandrashekar, EN Borducchi, LH Tostanoski, ... Nature 596 (7871), 268-272, 2021 | 312 | 2021 |
| Immunogenicity of the Ad26. COV2. S Vaccine for COVID-19 KE Stephenson, M Le Gars, J Sadoff, AM de Groot, D Heerwegh, ... Jama 325 (15), 1535-1544, 2021 | 312 | 2021 |
| Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys EN Borducchi, J Liu, JP Nkolola, AM Cadena, WH Yu, S Fischinger, ... Nature 563 (7731), 360-364, 2018 | 309 | 2018 |
| Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by HIV envelope trimer immunization using optimized approaches M Pauthner, C Havenar-Daughton, D Sok, JP Nkolola, R Bastidas, ... Immunity 46 (6), 1073-1088. e6, 2017 | 295 | 2017 |
| Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys EN Borducchi, C Cabral, KE Stephenson, J Liu, P Abbink, D Ng’ang’a, ... Nature 540 (7632), 284-287, 2016 | 284 | 2016 |
| Durable humoral and cellular immune responses 8 months after Ad26. COV2. S vaccination DH Barouch, KE Stephenson, J Sadoff, J Yu, A Chang, M Gebre, ... New England Journal of Medicine 385 (10), 951-953, 2021 | 236 | 2021 |
| Differential kinetics of immune responses elicited by Covid-19 vaccines AY Collier, J Yu, K McMahan, J Liu, A Chandrashekar, JS Maron, C Atyeo, ... New England Journal of Medicine 385 (21), 2010-2012, 2021 | 235 | 2021 |
| Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys M Aid, P Abbink, RA Larocca, M Boyd, R Nityanandam, O Nanayakkara, ... Cell 169 (4), 610-620. e14, 2017 | 215 | 2017 |
| Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques M Aid, K Busman-Sahay, SJ Vidal, Z Maliga, S Bondoc, C Starke, M Terry, ... Cell 183 (5), 1354-1366. e13, 2020 | 209 | 2020 |
| Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo … K Modjarrad, L Lin, SL George, KE Stephenson, KH Eckels, ... The Lancet 391 (10120), 563-571, 2018 | 203 | 2018 |
